Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: A systematic review and meta-analysis

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 122-129

  Lu, Xiu Lan ^a   Xiao, Zheng Hui ^a   Yang, Mei Yu ^a   Zhu, Yi Min ^a  

^a HUNAN CHILDREN'S HOSPITAL   (China)

Author keywords

bacterial infection; chronic renal insufficiency; procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; BACTERIAL INFECTION; BIVARIATE ANALYSIS; CHRONIC KIDNEY FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; HUMANS; PROTEIN PRECURSORS; RENAL INSUFFICIENCY, CHRONIC; SENSITIVITY AND SPECIFICITY;

EID: 84872231730     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs339     Document Type: Article

References (41)

1. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009; 29: 297-302
2. James MT, Laupland KB, Tonelli M et al. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 2008; 168: 2333-2339
3. James MT, Quan H, Tonelli M et al. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009; 54: 24-32
4. Mactier R. Peritonitis is still the achilles' heel of peritoneal dialysis. Perit Dial Int 2009; 29: 262-266
5. Reynvoet E, Vandijck DM, Blot SI et al. Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med 2009; 37: 2203-2209
6. Hildebrand A, Komenda P, Miller L et al. Peritonitis and exit site infections in First Nations patients on peritoneal dialysis. Clin J Am Soc Nephrol 2010; 5: 1988-1995
7. Lai KN, Leung JC. Inflammation in peritoneal dialysis. Nephron Clin Pract 2010; 116: c11-c18
8. Panichi V, Migliori M, De Pietro S et al. The link of biocompatibility to cytokine production. Kidney Int Suppl 2000; 76: S96-S103
9. Panichi V, Migliori M, De Pietro S et al. C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 2000; 18: 183-190
10. Panichi V, Migliori M, De Pietro S et al. C reactive protein in patients with chronic renal diseases. Ren Fail 2001; 23: 551-562
11. Simon L, Gauvin F, Amre DK et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217
12. Tang H, Huang T, Jing J et al. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009; 37: 497-507
13. Jones AE, Fiechtl JF, BrownMD et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007; 50: 34-41
14. Guz G, Colak B, Hizel K et al. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 2006; 26: 240-248
15. Herget-Rosenthal S, Marggraf G, Pietruck F et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001; 16: 975-979
16. Lam MF, Leung JC, Lam CW et al. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 2008; 28: 377-384
17. Öztürk R, Yilmaz GR, Bulut C et al. Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis. Turk J Med Sci 2010; 40: 199-206.
18. Steinbach G, Bolke E, Grunert A et al. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004; 116: 849-853
19. Yilmaz FM, Yilmaz G, Akay H et al. Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 2007; 44(Pt 5): 482-484
20. Amour J, Birenbaum A, Langeron O et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008; 36: 1147-1154
21. Deville WL, Buntinx F, Bouter LM et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2: 9
22. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006; 187: 271-281
23. Leeflang MM, Deeks JJ, Gatsonis C et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008; 149: 889-897
24. Whiting P, Rutjes AW, Reitsma JB et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25
25. Reitsma JB, Glas AS, Rutjes AW et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: 982-990
26. Macaskill P. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol 2004; 57: 925-932
27. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002; 21: 1525-1537
28. Song F, Khan KS, Dinnes J et al. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 2002; 31: 88-95
29. Akbulut H, Celik I, Ozden M et al. Plasma procalcitonin levels in chronic haemodialysis patients. Turk J Med Sci 2005; 35: 241-244
30. Bulut C, Ozturk R, Yilmaz GR et al. Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks. Mikrobiyol Bul 2008; 42: 255-264
31. Level C, Chauveau P, Delmas Y et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001; 16: 980-986
32. Lorton F, Veinberg F, Ielsch D et al. Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatr Nephrol 2007; 22: 430-435
33. Sitter T, Schmidt M, Schneider S et al. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2002; 15: 297-301
34. Visvardis G, Griveas I, Fleva A et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Ren Fail 2005; 27: 429-434
35. Dahaba AA, Elawady GA, Rehak PH et al. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care 2002; 30: 269-274
36. Meisner M, Huttemann E, Lohs T et al. Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 2000; 17: 665-671
37. Meisner M, Huttemann E, Lohs T et al. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 2001; 15: 171-175
38. Meisner M, Lohs T, Huettemann E et al. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001; 18: 79-87
39. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365: 1500-1505
40. Cornelis T, Bargman JM, Chu M et al. Discordant PD catheter and effluent culture results. The limited clinical relevance of culturing PD catheters. Perit Dial Int 2011; 31: 173-178
41. Herget-Rosenthal S, Klein T, Marggraf G et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 2005; 61: 180-186